6-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid

Catalog No.: 
ACXALP017
CAS No.: 
134372-47-7
Molecular Formula: 
C9H8ClNO3
Molecular Weight: 
213.62
6-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%
100mg95%
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid
IUPAC Name6-chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid
MDL No.MFCD22384391
Molecular FormulaC9H8ClNO3
Molecular Weight213.62
SMILESO=C(C1=C2OCCNC2=CC(Cl)=C1)O
InChI KeyRDIXXNVIEWPZCD-UHFFFAOYSA-N
Synonym6-chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid;6-Chloro-3,4-dihydro-2H-1,4-benzoxazine-8-carboxylic acid;6-Chloro-3,4-dihydro-2H-benzo[1,4]oxazine-8-carboxylic acid;2H-1,4-Benzoxazine-8-carboxylic acid, 6-chloro-3,4-dihydro-
CAS No.134372-47-7
PubChem CID10608651

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXALP017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMAOU845 route compound structure diagram
    ACMAOU845123040-45-9In Stock
  2. Then
  3. ACXALP017 route product structure diagram
    ACXALP017134372-47-7In Stock
Inquiry

2. ACXALP017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXALP017 route product structure diagram
    ACXALP017134372-47-7In Stock
Inquiry

3. ACXALP017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXALP017 route product structure diagram
    ACXALP017134372-47-7In Stock
Inquiry

Comments (0)